| Literature DB >> 33725270 |
Pablo Eduardo Logroño Wiese1, Frank Seeber2, Anne-Sophie Endres3, Claudia Brockmann4,5, Uwe Pleyer4.
Abstract
PURPOSE: Studies on the occurrence of ocular toxoplasmosis (OT) in a general population are rare. Therefore, we conducted this pilot study to assess whether a nonmydriatic ultra-wide-field (UWF) scanning laser ophthalmoscope (SLO) is suitable for a simple, rapid screening procedure.Entities:
Keywords: Geriatric screening; Ocular toxoplasmosis; T. gondii; Ultra-wide-field scanning laser ophthalmoscopy
Mesh:
Year: 2021 PMID: 33725270 PMCID: PMC8087594 DOI: 10.1007/s10792-020-01683-z
Source DB: PubMed Journal: Int Ophthalmol ISSN: 0165-5701 Impact factor: 2.031
Sample demographics: age and gender distribution (n = 101)
| Age group: | Participants (101) | Male (38) | Female (63) |
|---|---|---|---|
| < 50 | 2 (1.98%) | 2 (1.98%) | 0 (0.00%) |
| 50–59 | 6 (5.94%) | 2 (1.98%) | 4 (3.96%) |
| 60–69 | 8 (7.92%) | 2 (1.98%) | 6 (5.94%) |
| 70–79 | 43 (42.57%) | 21 (20.79%) | 22 (21.78%) |
| 80–89 | 38 (37.62%) | 9 (8.91%) | 29 (28.71%) |
| > 90 | 4 (3.96%) | 2 (1.98%) | 2 (1.98%) |
Fig. 1Clinical appearance of toxoplasmic retinochoroiditis. a Superonasal perivascular lesions in proximity to the optic disk, b superopapillary chorioretinal lesion with pigmentary changes and signs of cicatrization; c and d fundus autofluorescence of the corresponding lesions revealing the true extent of the underlying chorioatrophic injury (arrows)
Identified comorbidities based on clinical history: systemic risk factors (n = 101)
| Comorbidities: (DSM-Code) | Participants (101) | Male (38) | Female (63) |
|---|---|---|---|
| Cardiovascular | |||
| (I10) Arterial hypertension | 68 (67.33%) | 23 (22.77%) | 45 (44.55%) |
| (I25) Ischemic heart disease | 25 (24.75%) | 15 (14.85%) | 10 (9.90%) |
| (I34-37) Valvular heart disease | 28 (27.72%) | 10 (9.90%) | 18 (17.82%) |
| (I44-45) Atrioventricular block | 17 (16.83%) | 9 (8.91%) | 8 (7.92%) |
| (I48) Atrial fibrillation | 26 (25.74%) | 15 (14.85%) | 11 (10.89%) |
| (I50) Heart failure | 24 (23.76%) | 13 (12.87%) | 11 (10.89%) |
| (I73) Peripheral arterial occlusive disease | 6 (5.94%) | 2 (1.98%) | 4 (3.96%) |
| (F17) Nicotine dependence | 12 (11.88%) | 6 (5.94%) | 6 (5.94%) |
| (E11) Diabetes mellitus | 26 (25.74%) | 12 (11.88%) | 14 (13.86%) |
| (E66) Obesity | 11 (10.89%) | 5 (4.95%) | 6 (5.94%) |
| (E78) Dyslipidemia | 40 (39.60%) | 15 (14.85%) | 25 (24.75%) |
| Renal | |||
| (N18) Chronic kidney disease | 32 (31.68%) | 15 (14.85%) | 16 (15.84%) |
| Inflammatory | |||
| (L40) Psoriasis | 1.98% (2) | 1 (0.99%) | 1 (0.99%) |
| (M06) Rheumatoid arthritis | 6 (5.94%) | 1 (0.99%) | 5 (4.95%) |
| Neurologic | |||
| (G12) Amyotrophic lateral sclerosis | 1 (0.99%) | 0 (0.00%) | 1 (0.99%) |
| (G20) Parkinson’s disease | 3 (2.97%) | 1 (0.99%) | 2 (1.98%) |
| (G70) Myasthenia gravis | 1 (0.99%) | 1 (0.99%) | 0 (0.00%) |
| (G81) Hemiparesis | 11 (10.89%) | 4 (3.96%) | 7 (6.93%) |
| (I63) Cerebral infarction | 28 (27.72%) | 13 (12.87%) | 15 (14.85%) |
| (I65) Carotid artery stenosis | 5 (4.95%) | 1 (0.99%) | 4 (3.96%) |
| Oncologic | |||
| (N42) Prostatic carcinoma | 1 (0.99%) | 1 (0.99%) | 0 (0.00%) |
| (C50) Mammary carcinoma | 2 (1.98%) | 0 (0.00%) | 2 (1.98%) |
| (C34) Lung carcinoma | 2 (1.98%) | 0 (0.00%) | 2 (1.98%) |
| (Z85) Colon carcinoma | 3 (2.97%) | 1 (0.99%) | 2 (1.98%) |
| (C43) Skin melanoma | 2 (1.98%) | 1 (0.99%) | 1 (0.99%) |
| (C44) Squamous cell carcinoma | 3 (2.97%) | 1 (0.99%) | 2 (1.98%) |
| (C83) B cell lymphoma | 1 (0.99%) | 0 (0.00%) | 1 (0.99%) |
Fig. 2Wide-field fundus photographs (amplified) of a participant with severe undiagnosed bilateral carotid atheromatosis, showing marked venous tortuosity (arrows), venous beading and cotton wool spots
Fig. 3Wide-field fundus photograph showing peripheral neovascularization (amplification) in a diabetic participant
Clinical findings in the posterior segment based on anatomic location. n = 201
| Participants (101) | Male (38) | Female (63) | |||
|---|---|---|---|---|---|
| Fundoscopic findings: | Eyes (201) | OD (38) | OS (37) | OD (63) | OS (63) |
| Asteroid hyalosis | 3 (1.49%) | 1 (0.50%) | 0 (0.00%) | 2 (1.00%) | 0 (0.00%) |
| Floaters | 68 (33.83%) | 12 (5.97%) | 10 (4.98%) | 21 (10.45%) | 25 (12.44%) |
| Bergmeister’s papilla | 1 (0.50%) | 0 (0.00%) | 0 (0.00%) | 1 (0.50%) | 0 (0.00%) |
| Myelinated fibers | 1 (0.50%) | 0 (0.00%) | 0 (0.00%) | 1 (0.50%) | 0 (0.00%) |
| Hemorrhage | 3 (1.49%) | 0 (0.00%) | 0 (0.00%) | 1 (0.50%) | 2 (1.00%) |
| Tilted disk | 8 (3.98%) | 1 (0.50%) | 2 (1.00%) | 1 (0.50%) | 4 (1.99%) |
| Peripapillary atrophy | 54 (26.87%) | 7 (3.48%) | 8 (3.98%) | 20 (9.95%) | 19 (9.45%) |
| Elevated cup-to-disk ratio | 86 (42.79%) | 20 (9.95%) | 19 (9.45%) | 24 (11.94%) | 23 (11.44%) |
| Glaucoma suspect | 56 (27.86%) | 13 (6.47%) | 12 (5.97%) | 15 (7.46%) | 16 (7.96%) |
| Posterior staphyloma | 4 (1.99%) | 0 (0.00%) | 0 (0.00%) | 2 (1.00%) | 2 (1.00%) |
| Epiretinal membrane | 8 (3.98%) | 3 (1.49%) | 3 (1.49%) | 1 (0.50%) | 1 (0.50%) |
| Macular hole | 1 (0.50%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 1 (0.50%) |
| Hard exudates | 1 (0.50%) | 0 (0.00%) | 0 (0.00%) | 1 (0.50%) | 0 (0.00%) |
| Cotton wool spots | 1 (0.50%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 1 (0.50%) |
| Hemorrhage | 4 (1.99%) | 0 (0.00%) | 1 (0.50%) | 0 (0.00%) | 3 (1.49%) |
| Macular edema | 6 (2.99%) | 1 (0.50%) | 1 (0.50%) | 1 (0.50%) | 3 (1.49%) |
| Pigment displacement | 44 (21.89%) | 4 (1.99%) | 3 (1.49%) | 18 (8.96%) | 19 (9.45%) |
| Drusen | 39 (19.40%) | 6 (2.99%) | 5 (2.49%) | 13 (6.47%) | 15 (7.46%) |
| Macular degeneration | 18 (8.96%) | 2 (1.00%) | 3 (1.49%) | 6 (2.99%) | 7 (3.48%) |
| Geographic atrophy | 9 (4.48%) | 2 (1.00%) | 4 (1.99%) | 2 (1.00%) | 1 (0.50%) |
| Branch retinal vein occlusion | 3 (1.49%) | 2 (1.00%) | 0 (0.00%) | 0 (0.00%) | 1 (0.50%) |
| Hypertensive retinopathy | 91 (45.27%) | 17 (8.46%) | 17 (8.46%) | 28 (13.93%) | 29 (14.43%) |
| Vascular tortuosity | 43 (21.93%) | 9 (4.48%) | 12 (5.97%) | 11 (5.47%) | 11 (5.47%) |
| Arteriolar narrowing | 72 (35.82%) | 13 (6.47%) | 17 (8.46%) | 22 (10.95%) | 21 (10.45%) |
| Arteriovenous nicking | 26 (12.94%) | 4 (1.99%) | 5 (2.49%) | 8 (3.98%) | 9 (4.48%) |
| Copper wire arterioles | 4 (1.99%) | 1 (0.50%) | 0 (0.00%) | 2 (1.00%) | 1 (0.50%) |
| Silver wire arterioles | 12 (5.97%) | 2 (1.00%) | 3 (1.49%) | 1 (0.50%) | 6 (2.99%) |
| Venous beading | 6 (2.99%) | 1 (0.50%) | 1 (0.50%) | 2 (1.00%) | 2 (1.00%) |
| Diabetic retinopathy | 5 (2.49%) | 2 (1.00%) | 2 (1.00%) | 0 (0.00%) | 1 (0.50%) |
| Neoproliferative seafan | 1 (0.50%) | 0 (0.00%) | 1 (0.50%) | 0 (0.00%) | 0 (0.00%) |
| Toxoplasmosis lesion | 4 (1.99%) | 0 (0.00%) | 0 (0.00%) | 3 (1.49%) | 1 (0.50%) |
| Photocoagulation scar | 6 (2.99%) | 1 (0.50%) | 1 (0.50%) | 0 (0.00%) | 4 (1.99%) |
| Chorioretinal atrophy | 15 (7.46%) | 3 (1.49%) | 4 (1.99%) | 2 (1.00%) | 6 (2.99%) |
| Chorioretinal nevus | 13 (6.47%) | 4 (1.99%) | 3 (1.49%) | 4 (1.99%) | 2 (1.00%) |
| Drusen | 40 (19.90%) | 5 (2.49%) | 5 (2.49%) | 13 (6.47%) | 17 (8.46%) |
| Hemorrhage | 22 (10.95%) | 3 (1.49%) | 10 (4.98%) | 5 (2.49%) | 4 (1.99%) |
| Cobblestone degeneration | 9 (4.48%) | 1 (0.50%) | 1 (0.50%) | 3 (1.49%) | 4 (1.99%) |
Fig. 4Wide-field color fundus photograph of a left eye showing a peripheral retinochoroidal scar due to focal photocoagulation (arrow)
Fig. 5Wide-field fundus photographs of a participant with Cobblestone degeneration on both eyes (black arrows), also showing an epiretinal membrane (white arrows) in the left eye